SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-002248
Filing Date
2020-01-08
Accepted
2020-01-08 16:00:33
Documents
6
Period of Report
2020-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201356-1_8k.htm 8-K 20416
2 EXHIBIT 10.1 tm201356d1_ex10-1.htm EX-10.1 204015
3 EXHIBIT 10.2 tm201356d1_ex10-2.htm EX-10.2 43382
4 EXHIBIT 99.1 tm201356d1_ex99-1.htm EX-99.1 13383
5 GRAPHIC tm201356d1_ex99-1img01.jpg GRAPHIC 10855
6 GRAPHIC tm201356d1_ex99-1img02.jpg GRAPHIC 10947
  Complete submission text file 0001104659-20-002248.txt   312893
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 20515772
SIC: 2834 Pharmaceutical Preparations